Ceo Aummis (The Collider Programme) (Valencia)

Ceo Aummis (The Collider Programme) (Valencia)

04 nov
|
FORESEE
|
Valencia

04 nov

FORESEE

Valencia

Valencia, Spain Call4Entrepreneurs - The Collider

About the job CEO AUMMIS (The Collider Programme)

CEO AUMMIS (The Collider Programme)

AUMMIS | Stem-free Uterine Manipulator for Minimally Invasive Surgery

CEO & Co-Founder Opportunity |

MedTech | Gynecologic Oncology

Laparoscopic hysterectomy depends on a uterine manipulator, and almost every model on the market works by inserting a rigid stem into the uterus.

Clinical evidence has linked these manipulators to a higher risk of cancer recurrence

, because the stem damages tissue, manipulates the tumor and can spread malignant cells.

As a result, many oncology patients still undergo open surgery.

AUMMIS removes the stem.

Its vacuum-assisted system holds the cervix with interchangeable cups, so surgeons can mobilize the uterus in laparoscopic and robotic surgery without traumatizing tissue or touching the tumor.

The project was born at

FISABIO and

Universitat Jaume I

, and is now looking for the CEO who will turn it into a company.

Where AUMMIS stands today

Functional prototype

, with proof of concept completed on cadaveric bodies (

TRL 4

)

Granted Spanish patent

, with

EPO and US applications pending and freedom to operate confirmed in Europe and the US

Classified as a

Class IIa medical device

~1.3 million hysterectomies performed worldwide every year A market dominated by large surgical device players whose manipulators are mostly stem-based, a clear path to licensing or strategic partnership A defined roadmap to

CE marking

, with pilot clinical studies planned for and a financial strategy combining non-dilutive funding and private investment

€143K grant from the Valencian Innovation Agency (AVI)

, co-funded by the EU (ERDF), to advance development, validation and transfer of the device The founding team

Dr. J.

Antonio Llueca

Abella

– Future CSO.

A gynecologic oncology surgeon and Principal Clinical Investigator at FISABIO, he identified the problem in the operating room.





By the end of the 4-month validation phase, you will have:

A defined business model and partnering strategy

: licensing, co-development or a path to direct sales

A regulatory and clinical roadmap under MDR, toward CE marking and FDA

A funding plan for the next 24 months

, combining non-dilutive programmes and private investment

First conversations opened with medical device manufacturers and distributors

Agreement with the founding team on the company structure and spin-off creation The Offer

Significant co-founder equity stake as CEO upon company incorporation

€8,000 stipend during the validation phase (4 monthly instalments of €2,000)

Opportunity to access a participative loan of up to €75,000

to finance the first phases of the project The Collider venture-building programme

: mentors and specialists in medtech, IP, regulatory, go-to-market and fundraising, plus support with spin-off creation

International exposure through The Collider ecosystem (4YFN, Mobile World Congress, corporate & investor networks)

Two years of post-incorporation support

, including in-kind services, community access and portfolio perks

Expected start

February-March

What you bring

Previous founder or early-stage startup experience

Proven track record in the medical device industry

, in BD, product, regulatory or general management, ideally with surgical devices or disposables

Hands-on experience moving a device through MDR/CE or running clinical studies.

You know what it takes to go from prototype to first-in-human.

A network in the medtech industry

: manufacturers, distributors or strategic partners

Experience closing deals

, such as licensing, partnerships or fundraising, including non-dilutive funding (EU, CDTI or similar)

Ability to translate clinical evidence into a business case that convinces partners, investors and regulators, working closely with surgeons and engineers

Eligible to work in Spain and fluent in

Spanish and English

Background in gynecology, oncology or minimally invasive and robotic surgery

📌 Ceo Aummis (The Collider Programme) (Valencia)
🏢 FORESEE
📍 Valencia

Postulate a este anuncio

Muestra tus habilidades a la empresa, rellenar el formulario y deja un toque personal en la carta, ayudará el reclutador en la elección del candidato.

Suscribete a esta alerta:

Recibe por email las nuevas ofertas de trabajo para: ceo aummis (the collider programme) (valencia) / valencia

Suscribete a esta alerta:

Recibe por email las nuevas ofertas de trabajo para: ceo aummis (the collider programme) (valencia) / valencia